KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025)

Historic Dividends Paid - Common for Regeneron Pharmaceuticals (REGN) over the last 1 years, with Q4 2025 value amounting to $92.7 million.

  • Regeneron Pharmaceuticals' Dividends Paid - Common changed N/A to $92.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $370.3 million, marking a year-over-year change of. This contributed to the annual value of $370.3 million for FY2025, which is N/A changed from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Dividends Paid - Common of $92.7 million as of Q4 2025.
  • Regeneron Pharmaceuticals' 5-year Dividends Paid - Common high stood at $93.8 million for Q1 2025, and its period low was $91.2 million during Q3 2025.